Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction

Heart. 2007 Jul;93(7):864-6. doi: 10.1136/hrt.2007.124305.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Aspirin / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Life Style
  • Myocardial Infarction / prevention & control*
  • Myocardial Revascularization / methods
  • Practice Guidelines as Topic*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Aspirin